FDA approved the therapy, called Kymriah, in children and young adults with acute lymphoblastic leukemia whose disease has come back in spite of previous treatments.
from USATODAY - News Top Stories http://ift.tt/2xz3hfU
via IFTTT
Wednesday, August 30, 2017
Subscribe to:
Post Comments (Atom)
Revolutionary gene therapy approved for leukemia — at $475,000 price tag